MABTHERA Side Effects

7023548-2 |
on Sep 16, 2010 Male patient from UNITED KINGDOM , 29 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). . Mabthera dosage: 1000 Mg, X1. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ).

7023387-2 | Cerebral Infarction
Patient was taking Mabthera (View Usage). Patient had the following side effects: cerebral infarction on Sep 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with diffuse large b-cell lymphoma and. Mabthera dosage: 375 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (100 Mg, Unk) (View Prednisone Review and Prednisone Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), FENISTIL (View Fenistil Review and Fenistil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SODIUM CHLORIDE (1.5 Unk, Unk) (View Sodium Chloride Review and Sodium Chloride Label ).

7021451-5 | Immune System Disorder
Adverse event was reported on Sep 15, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 650 Mg, Q4w) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED KINGDOM , weighting 122.4 lb, After Mabthera was administered, patient had the following side effects: immune system disorder. During the same period patient was treated with BENDAMUSTINE (Unk) (View Bendamustine Review and Bendamustine Label ), PREDNISONE (50 Mg, Unk) (View Prednisone Review and Prednisone Label ), PARACETAMOL (1000 Mg, Unk) (View Paracetamol Review and Paracetamol Label ), CLEMASTINE FUMARATE (2 Mg, Unk) (View Clemastine Fumarate Review and Clemastine Fumarate Label ).

7021433-3 | Gastrointestinal Infection, Immunodeficiency
on Sep 15, 2010 Female patient from UNITED KINGDOM , weighting 132.3 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal infection, immunodeficiency. Mabthera dosage: 650 Mg, Q4w. During the same period patient was treated with BENDAMUSTINE (Unk) (View Bendamustine Review and Bendamustine Label ), PREDNISONE (50 Mg, Unk) (View Prednisone Review and Prednisone Label ), CLEMASTINE FUMARATE (Unk) (View Clemastine Fumarate Review and Clemastine Fumarate Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), PARACETAMOL (1500 Mg, Unk) (View Paracetamol Review and Paracetamol Label ).


7021430-8 | Febrile Neutropenia, Paraparesis, Paraplegia, Progressive Multifocal Leukoencephalopathy
on Sep 16, 2010 Female patient from UNITED KINGDOM , weighting 121.3 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient had the following side effects: febrile neutropenia, paraparesis, paraplegia, progressive multifocal leukoencephalopathy. Mabthera dosage: 550 Mg, Unk. During the same period patient was treated with ARA C (2000 Mg, Unk) (View Ara-c Review and Ara-c Label ), ARA C (2000 Mg, Unk) (View Ara-c Review and Ara-c Label ), DEXAMETASONE (40 Mg, Unk) (View Dexametasone Review and Dexametasone Label ), CISPLATIN (150 Mg, Unk) (View Cisplatin Review and Cisplatin Label ), DOXORUBICIN HCL (90 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized and became disabled.

7019517-9 | Abdominal Discomfort, Asthenia, Decreased Appetite, Fatigue, Gamma-glutamyltransferase Increased, Malaise, Nausea
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: abdominal discomfort, asthenia, decreased appetite, fatigue, gamma-glutamyltransferase increased, malaise, nausea (What is nausea?) on Sep 14, 2010 from GERMANY Additional patient health information: Male patient , weighting 220.5 lb, was diagnosed with b-cell lymphoma and. Mabthera dosage: 375 Mg/m2, Unk. During the same period patient was treated with PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), CLEMASTINE FUMARATE (Unk) (View Clemastine Fumarate Review and Clemastine Fumarate Label ).

7019206-0 | Acute Lymphocytic Leukaemia, Asthenia, Cardiomegaly, Contusion, Diarrhoea, Dry Mouth, Flatulence, Haematoma, Hypotension
Adverse event was reported on Sep 14, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), myocardial ischaemia and. Location: UNITED KINGDOM , 75 years of age, Patient experienced the following unwanted or unexpected effects: acute lymphocytic leukaemia, asthenia, cardiomegaly, contusion, diarrhoea, dry mouth, flatulence, haematoma, hypotension. During the same period patient was treated with ADCAL D3 (Unk) (View Adcal D3 Review and Adcal D3 Label ), ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ).

7016805-7 | Mucosal Inflammation, Upper Gastrointestinal Haemorrhage
on Sep 14, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera (View Usage). Patient had the following side effects: mucosal inflammation, upper gastrointestinal haemorrhage. Mabthera dosage: 375 Mg/m2, Unk. Patient was hospitalized.

7016778-7 | Completed Suicide
on Sep 13, 2010 Male patient from UNITED KINGDOM , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: completed suicide. Mabthera dosage: Unk.

7016777-5 | Bradycardia, Erythema, Hyperhidrosis, Hypotension, Musculoskeletal Stiffness, Nausea, Unresponsive To Stimuli
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, erythema, hyperhidrosis, hypotension, musculoskeletal stiffness, nausea (What is nausea?), unresponsive to stimuli on Sep 14, 2010 from IRELAND Additional patient health information: Male patient , weighting 151.9 lb, was diagnosed with chronic lymphocytic leukaemia and. Mabthera dosage: 700 Mg, Q28d.

7010607-3 | Renal Failure
Adverse event was reported on Sep 10, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 1000 Mg, X2) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED KINGDOM , weighting 114.6 lb, Patient had the following side effects: renal failure. Patient was hospitalized.

7008039-7 | Colitis
on Sep 09, 2010 Female patient from UNITED KINGDOM , 24 years of age, was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: colitis. Mabthera dosage: Unk. During the same period patient was treated with FOLACIN (View Folacin Review and Folacin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ORUDIS (View Orudis Review and Orudis Label ). Patient was hospitalized.

6994610-5 | Arthralgia, Arthritis, Gait Disturbance, Menorrhagia
on Sep 06, 2010 Female patient from BRAZIL , weighting 125.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, osteopenia, gastritis and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), gait disturbance, menorrhagia. Mabthera dosage: Unk. During the same period patient was treated with ACTEMRA (480 Mg, 1/month) (View Actemra Review and Actemra Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHOTREXATE (2.5 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (5 Mg, 5/week) (View Folic Acid Review and Folic Acid Label ), ETORICOXIB (Unk) (View Etoricoxib Review and Etoricoxib Label ), ALENDRONATE SODIUM (70 Mg, 1/week) (View Alendronate Sodium Review and Alendronate Sodium Label ), PANTOPRAZOLE (Unk) (View Pantoprazole Review and Pantoprazole Label ), METICORTEN (20 Mg, Unk) (View Meticorten Review and Meticorten Label ).

6988845-5 | Pneumocystis Jiroveci Pneumonia
Patient was taking Mabthera (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia on Aug 31, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 21 years of age, was diagnosed with diffuse large b-cell lymphoma and. Mabthera dosage: 375 Mg/m2, Q2w. During the same period patient was treated with CYCLOPHOSPHAMIDE (750 Mg/m2, Q2w) (View Cyclophosphamide Review and Cyclophosphamide Label ), ADRIAMYCIN PFS (50 Mg/m2, Q2w) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VINCRISTINE (1.4 Mg/m2, Q2w) (View Vincristine Review and Vincristine Label ), PREDNISONE (100 Mg, Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6988843-1 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Aug 31, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with diffuse large b-cell lymphoma, hypoaesthesia facial and. Location: UNITED KINGDOM , 51 years of age, After Mabthera was administered, patient had the following side effects: pneumocystis jiroveci pneumonia. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), CYTARABINE (Unk) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6988841-8 | Idiopathic Pulmonary Fibrosis
on Sep 03, 2010 Female patient from UNITED KINGDOM , 63 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic pulmonary fibrosis. Mabthera dosage: 375 Mg/m2, Unk.

6988773-5 | Renal Failure
on Sep 03, 2010 Female patient from UNITED KINGDOM , 23 years of age, weighting 114.6 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Mabthera (View Usage). Patient had the following side effects: renal failure. Mabthera dosage: 1 G, X2. Patient was hospitalized.

6988754-1 | Agranulocytosis
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: agranulocytosis on Sep 03, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: Unk. During the same period patient was treated with NOVATREX (20 Mg, 1/week) (View Novatrex Review and Novatrex Label ), SPECIAFOLDINE (10 Mg, 1/week) (View Speciafoldine Review and Speciafoldine Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6986103-6 | Febrile Neutropenia, Paraparesis, Paraplegia, Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Aug 12, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 550 Mg, Unk) was diagnosed with diffuse large b-cell lymphoma and. Location: UNITED KINGDOM , weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: febrile neutropenia, paraparesis, paraplegia, progressive multifocal leukoencephalopathy. During the same period patient was treated with ARA C (2000 Mg, Unk) (View Ara-c Review and Ara-c Label ), DEXAMETASONE (40 Mg, Unk) (View Dexametasone Review and Dexametasone Label ), CISPLATIN (150 Mg, Unk) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized and became disabled.

6974531-4 |
on Aug 31, 2010 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera (View Usage). . Mabthera dosage: Unk.

6974236-X | Bradycardia, Unresponsive To Stimuli
on Aug 25, 2010 Male patient from UNITED KINGDOM , 60 years of age, was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: bradycardia, unresponsive to stimuli. Mabthera dosage: Unk.

6973508-2 | Liver Disorder
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Aug 27, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, weighting 121.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), pyrexia and. Mabthera dosage: 2000 Mg, Unk. During the same period patient was treated with PARACETAMOL (1 G, Unk) (View Paracetamol Review and Paracetamol Label ), MTX (15 Mg, Unk) (View Mtx Review and Mtx Label ), PREDNISOLONE (5 Mg, Unk) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6971812-5 |
Adverse event was reported on Aug 31, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with systemic lupus erythematosus and. Location: UNITED KINGDOM , 45 years of age, .

6969329-7 | Anaemia, Cerebrovascular Accident, Leukocytosis, Neutropenia, Splenomegaly
on Aug 25, 2010 Male patient from FRANCE , weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: anaemia, cerebrovascular accident, leukocytosis, neutropenia, splenomegaly. Mabthera dosage: 375 Mg/m2, Unk. During the same period patient was treated with ADRIAMYCIN PFS (25 Mg/m2, Unk) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ENDOXAN (750 Mg/m2, Unk) (View Endoxan Review and Endoxan Label ), ONCOVIN (2 Mg, Unk) (View Oncovin Review and Oncovin Label ), SOLU MEDROL (60 Mg, Unk) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

6966238-4 | Malignant Urinary Tract Neoplasm
on Aug 23, 2010 Female patient from UNITED KINGDOM , 74 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: malignant urinary tract neoplasm. Mabthera dosage: 1 G, Unk. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6966232-3 | Arthralgia, Gestational Hypertension, Pain, Procedural Hypertension, Stress, Therapeutic Response Decreased
Patient was taking Mabthera (View Usage). Patient had the following side effects: arthralgia, gestational hypertension, pain (What is pain?), procedural hypertension, stress (What is stress?), therapeutic response decreased on Aug 24, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, was diagnosed with juvenile arthritis and. Mabthera dosage: Unk. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), CORTICOSTEROIDS (Unk) (View Corticosteroids Review and Corticosteroids Label ), HYDROXYCHLOROQUINE (Unk) (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.

6966218-9 | Premature Baby, Premature Rupture Of Membranes
Adverse event was reported on Aug 24, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with juvenile arthritis and. Location: UNITED KINGDOM , 36 years of age, After Mabthera was administered, patient had the following side effects: premature baby, premature rupture of membranes. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.

6965584-8 | Arthralgia, Arthritis, Gait Disturbance, Menorrhagia
on Aug 25, 2010 Female patient from BRAZIL , weighting 125.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, osteopenia, gastritis and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), gait disturbance, menorrhagia. Mabthera dosage: Unk. During the same period patient was treated with ACTEMRA (480 Mg, 1/month) (View Actemra Review and Actemra Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHOTREXATE (2.5 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (5 Mg, 5/week) (View Folic Acid Review and Folic Acid Label ), ETORICOXIB (Unk) (View Etoricoxib Review and Etoricoxib Label ), ALENDRONATE SODIUM (70 Mg, 1/week) (View Alendronate Sodium Review and Alendronate Sodium Label ), PANTOPRAZOLE (Unk) (View Pantoprazole Review and Pantoprazole Label ), METICORTEN (20 Mg, Unk) (View Meticorten Review and Meticorten Label ).

6963804-7 | Respiratory Tract Infection Viral, Tuberculosis
on Aug 25, 2010 Female patient from RUSSIAN FEDERATION , weighting 143.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). Patient had the following side effects: respiratory tract infection viral, tuberculosis (What is tuberculosis?). Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with METHOTREXATE (15 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), METHYLPREDNISOLONE (6 Mg, Qd) (View Methylprednisolone Review and Methylprednisolone Label ), NIMESULIDE (100 Mg, Qd) (View Nimesulide Review and Nimesulide Label ), OMEPRAZOLE (40 Mg, Qd) (View Omeprazole Review and Omeprazole Label ).

6961608-2 | Completed Suicide
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: completed suicide on Aug 23, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 57 years of age, . Mabthera dosage: Unk.

6955604-9 | Blood Pressure Decreased, Sepsis, Unevaluable Event
Adverse event was reported on Aug 17, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: 1000 Mg, Days 1+15) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 70 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, sepsis (What is sepsis?), unevaluable event. Patient was hospitalized.

6946222-7 | Cardiomyopathy
on Aug 17, 2010 Female patient from UNITED KINGDOM , 81 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Mabthera dosage: Unk. During the same period patient was treated with BLEOMYCIN (Unk) (View Bleomycin Review and Bleomycin Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), ETOPOSIDE (Unk) (View Etoposide Review and Etoposide Label ), MITOXANTRONE (12 Mg/m2, Q2w) (View Mitoxantrone Review and Mitoxantrone Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), ONDANSETRON (Unk) (View Ondansetron Review and Ondansetron Label ).

6946182-9 | Progressive Multifocal Leukoencephalopathy
on Aug 16, 2010 Female patient from UNITED KINGDOM , 50 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 1 G, Q6m. During the same period patient was treated with GENOXAL (1 G, Unk) (View Genoxal Review and Genoxal Label ), AZATHIOPRINE (Unk) (View Azathioprine Review and Azathioprine Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), BOSENTAN (Unk) (View Bosentan Review and Bosentan Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), ILOPROST TROMETAMOL (Unk) (View Iloprost Trometamol Review and Iloprost Trometamol Label ). Patient was hospitalized.

6945861-7 | Bradycardia, Hypertension, Unresponsive To Stimuli
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, hypertension, unresponsive to stimuli on Aug 17, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, weighting 213.8 lb, was diagnosed with non-hodgkin's lymphoma, hypercholesterolaemia, pain (What is pain?), erectile dysfunction (What is erectile dysfunction?) and. Mabthera dosage: 750 Mg, Unk. During the same period patient was treated with ATORVASTATIN (10 Mg, Unk) (View Atorvastatin Review and Atorvastatin Label ), CHLORPHENAMINE (10 Mg, Unk) (View Chlorphenamine Review and Chlorphenamine Label ), ACETAMINOPHEN (1 G, Unk) (View Acetaminophen Review and Acetaminophen Label ), SILDENAFIL (50 Mg, Unk) (View Sildenafil Review and Sildenafil Label ). Patient was hospitalized.

6943673-1 | Respiratory Tract Infection Viral, Tuberculosis
Adverse event was reported on Aug 16, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 1000 Mg, Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: RUSSIAN FEDERATION , weighting 143.3 lb, Patient had the following side effects: respiratory tract infection viral, tuberculosis (What is tuberculosis?). During the same period patient was treated with METHOTREXATE (15 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), METHYLPREDNISOLONE (6 Mg, Qd) (View Methylprednisolone Review and Methylprednisolone Label ), NIMESULIDE (100 Mg, Qd) (View Nimesulide Review and Nimesulide Label ), OMEPRAZOLE (40 Mg, Qd) (View Omeprazole Review and Omeprazole Label ).

6942990-9 | Progressive Multifocal Leukoencephalopathy
on Aug 16, 2010 Female patient from UNITED KINGDOM , 50 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 1 G, Q6m. During the same period patient was treated with GENOXAL (1 G, Unk) (View Genoxal Review and Genoxal Label ), AZATHIOPRINE (Unk) (View Azathioprine Review and Azathioprine Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), BOSENTAN (Unk) (View Bosentan Review and Bosentan Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), ILOPROST TROMETAMOL (Unk) (View Iloprost Trometamol Review and Iloprost Trometamol Label ). Patient was hospitalized.

6942918-1 | Febrile Neutropenia, Interstitial Lung Disease
on Aug 11, 2010 Female patient from UNITED KINGDOM , weighting 158.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, interstitial lung disease. Mabthera dosage: 675 Unk, Q21d. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6942913-2 | Joint Warmth, Malaise, Ocular Hyperaemia, Oedema Peripheral, Pain In Extremity, Pallor, Pruritus, Rheumatoid Arthritis, Skin Atrophy
Patient was taking Mabthera (View Usage). Patient had the following side effects: joint warmth, malaise, ocular hyperaemia, oedema peripheral, pain in extremity, pallor, pruritus, rheumatoid arthritis (What is rheumatoid arthritis?), skin atrophy on Aug 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 100 Mg/ml, Q14d. During the same period patient was treated with TOCILIZUMAB (530 Mg, Unk) (View Tocilizumab Review and Tocilizumab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PRELONE (View Prelone Review and Prelone Label ), MAREVAN (View Marevan Review and Marevan Label ), FELDENE (1 Tablet, Qd) (View Feldene Review and Feldene Label ), DORFLEX (3 Tablet, Qd) (View Dorflex Review and Dorflex Label ), FOLINA (View Folina Review and Folina Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ). Patient was hospitalized.

6939431-4 | Colitis Ulcerative
Adverse event was reported on Aug 12, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 23 years of age, After Mabthera was administered, patient had the following side effects: colitis ulcerative. During the same period patient was treated with METHOTREXATE (20 Mg, Unk) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6939334-5 | Febrile Neutropenia, Paraparesis, Paraplegia, Progressive Multifocal Leukoencephalopathy
on Aug 12, 2010 Female patient from UNITED KINGDOM , weighting 121.3 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, paraparesis, paraplegia, progressive multifocal leukoencephalopathy. Mabthera dosage: 550 Mg, Unk. During the same period patient was treated with ARA C (2000 Mg, Unk) (View Ara-c Review and Ara-c Label ), DEXAMETASONE (40 Mg, Unk) (View Dexametasone Review and Dexametasone Label ), CISPLATIN (150 Mg, Unk) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized and became disabled.

6934683-9 | Disease Progression
on Aug 10, 2010 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with dermatomyositis, pain (What is pain?) and was treated with Mabthera (View Usage). Patient had the following side effects: disease progression. Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with ACETAMINOPHEN (500 Mg, Prn) (View Acetaminophen Review and Acetaminophen Label ).

6932977-4 | Lung Neoplasm Malignant
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: lung neoplasm malignant on Aug 11, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: Unk. During the same period patient was treated with REMICADE (Unk) (View Remicade Review and Remicade Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), ARAVA (Unk) (View Arava Review and Arava Label ), KINERET (Unk) (View Kineret Review and Kineret Label ), HUMIRA (Unk) (View Humira Review and Humira Label ), ENBREL (Unk) (View Enbrel Review and Enbrel Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6932923-3 | Condition Aggravated, Convulsion, Dyspnoea, Oxygen Saturation Decreased, Pulmonary Fibrosis
Adverse event was reported on Aug 11, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 1 G, Bid) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 53 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, convulsion, dyspnoea, oxygen saturation decreased, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with CARBAMAZEPINE (Unk) (View Carbamazepine Review and Carbamazepine Label ), IBUPROFEN (Unk) (View Ibuprofen Review and Ibuprofen Label ), METHOTREXATE (22.5 G, Unk) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6931190-4 | Oedema Peripheral, Pain In Extremity, Purpura, Pyrexia
on Aug 04, 2010 Female patient from UNITED KINGDOM , 46 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Mabthera (View Usage). Patient had the following side effects: oedema peripheral, pain in extremity, purpura, pyrexia. Mabthera dosage: Unk. Patient was hospitalized.

6931172-2 | Hyperkalaemia, Renal Failure Acute
on Aug 10, 2010 Female patient from UNITED KINGDOM , 46 years of age, was diagnosed with diffuse large b-cell lymphoma, liver transplant (What is liver transplant?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: hyperkalaemia, renal failure acute. Mabthera dosage: Unk. During the same period patient was treated with TACROLIMUS (5 Mg, Unk) (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6930576-1 | Respiratory Tract Infection Viral, Tuberculosis
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory tract infection viral, tuberculosis (What is tuberculosis?) on Aug 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 44 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), GLUCOCORTICOID NOS (Unk) (View Glucocorticoid Nos Review and Glucocorticoid Nos Label ).

6929133-2 | Agranulocytosis
Adverse event was reported on Aug 05, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 1000 Mg, Q6m) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypothyroidism and. Location: UNITED KINGDOM , 65 years of age, Patient had the following side effects: agranulocytosis. During the same period patient was treated with METHYLPREDNISOLONE ACETATE (Unk) (View Methylprednisolone Acetate Review and Methylprednisolone Acetate Label ), THYROID HORMONE (Unk) (View Thyroid Hormone Review and Thyroid Hormone Label ). Patient was hospitalized.

6928133-6 | Haemorrhagic Stroke
on Aug 05, 2010 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: haemorrhagic stroke. Mabthera dosage: Unk.

6928129-4 | Acute Leukaemia, Myelodysplastic Syndrome, Pancytopenia
on Aug 05, 2010 Female patient from UNITED KINGDOM , weighting 174.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia, myelodysplastic syndrome, pancytopenia. Mabthera dosage: Unk. During the same period patient was treated with FLUDARA (Unk) (View Fludara Review and Fludara Label ), ENDOXAN (Unk) (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

6922173-9 | Embolism Arterial
Patient was taking Mabthera (View Usage). Patient had the following side effects: embolism arterial on Aug 02, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 12 years of age, was diagnosed with lupus nephritis and. Mabthera dosage: 500 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ).